KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Inventory (2017 - 2025)

Twist Bioscience (TWST) has disclosed Change in Inventory for 7 consecutive years, with -$4.3 million as the latest value for Q3 2023.

  • On a quarterly basis, Change in Inventory fell 15.89% to -$4.3 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$7.2 million, a 196.05% decrease, with the full-year FY2025 number at $4.2 million, up 152.96% from a year prior.
  • Change in Inventory was -$4.3 million for Q3 2023 at Twist Bioscience, down from -$3.6 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $10.6 million in Q3 2021 to a low of -$4.7 million in Q1 2023.
  • A 5-year average of $1.4 million and a median of $1.1 million in 2020 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: crashed 232.22% in 2019, then soared 1308.57% in 2021.
  • Twist Bioscience's Change in Inventory stood at $86000.0 in 2019, then surged by 1204.65% to $1.1 million in 2020, then surged by 651.87% to $8.4 million in 2021, then crashed by 37.4% to $5.3 million in 2022, then plummeted by 181.22% to -$4.3 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Change in Inventory are -$4.3 million (Q3 2023), -$3.6 million (Q2 2023), and -$4.7 million (Q1 2023).